| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89fa9dbbcdf8b9214a02386b1443e2c9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15043 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-02012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867 |
| filingDate |
2019-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fce2b7343036218792ab640fe96690d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af3d42a4f254f4b54ee4a5477fe6a99a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41602cc67b22c762bf82a79d9c331885
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dafaa59f16020b420443e811166368de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ed0e4015aaabbb44aa48855dca33a52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5e61cf84f14ee0fc8ec238621abe2d0 |
| publicationDate |
2020-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110964751-A |
| titleOfInvention |
A kind of NAMPT lentiviral vector and its biological preparation and application |
| abstract |
The invention discloses a NAMPT lentiviral vector and its biological preparation and application. The NAMPT lentiviral vector comprises a human NAMPT gene, and the nucleotide sequence of the NAMPT gene is shown in SEQ ID NO: 1. This lentiviral preparation is expressed in in vitro cultured cells and in local and systemic application experiments in mouse skin, and can increase the level of NAD+ in cells. The present invention also provides a related biological preparation of a lentiviral vector expressing hNAMPT gene, which improves the expression of NAMPT enzyme in individual cells after application. circulatory system, thereby increasing the level of NAD+ in cells throughout the body, achieving improved physical activity and anti-aging effects. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113234759-A |
| priorityDate |
2019-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |